Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Short Interest Down 59.8% in December

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 6,800 shares, a decrease of 59.8% from the November 30th total of 16,900 shares. Based on an average trading volume of 67,700 shares, the days-to-cover ratio is presently 0.1 days.

Awakn Life Sciences Stock Performance

Awakn Life Sciences stock opened at $0.07 on Friday. The business’s 50-day simple moving average is $0.08 and its 200 day simple moving average is $0.08. Awakn Life Sciences has a 12-month low of $0.05 and a 12-month high of $0.19.

Awakn Life Sciences Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.